Study of Combined VisioCyt Test and FGFR3 Mutations on a Urinary Sample to Diagnose Bladder Tumors
Clinical trial NCT05151341 · COMPLETED
Trial details
- NCT number
- NCT05151341
- Sponsor
- Institut de Cancérologie de Lorraine
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-13
- Primary completion
- 2024-12-12
- Enrollment
- 190
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.